Intervenção farmacêutica na cessação tabágica em uma drogaria : relato de caso.

Abstract

Smoking in Brazil accounts for about half of the 10 leading causes of death: ischemic heart disease (14.9%), neoplasias (17.4%), cerebrovascular diseases, including systemic arterial hypertension (12.4% %) and COPD (5.3%). The relevance of this research is based on the patients' need to quit smoking, thus promoting better living conditions in the future, and the pharmacist can contribute to a more successful treatment. The objective of this study was to evaluate the efficacy of pharmaceutical interventions in the promotion of smoking cessation through awareness of the harm caused to smokers. The study was designed as an intervention, aimed at attending to the chronic tobacco user population. It was conducted at the Novázad pharmacies branch 2 in the city of Encruzilhada do Sul. Five volunteers were selected with acceptance criteria for volunteers who had tried and failed in stop smoking, as well as not participating in another smoking cessation program. The study was submitted to the Research Ethics Committee (CEP) of the University of Santa Cruz do Sul (UNISC) under the number CAAE 03841118.0.0000.5343. Pharmaceutical monitoring was done by working on patient awareness that they were on nicotine replacement therapy or nicotine replacement associated with bupropion. He also counted on face-to-face meetings and messages during the study period, thus seeking to motivate them to quit smoking. Of the five smoking patients participating in the smoking cessation program, three (60%) were successful. With these results we can see how important is the performance of the pharmacist in the cessation of smoking, contributing to a health promotion, improving the quality of life of individuals in the presence of the pharmaceutical professional in drugstores allows a service easily accessible to the population and with good success rates.